Marcus Ohlsson

Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial

Piotr Ponikowski, Bridget‐Anne Kirwan, Stefan D. Anker et al. · The Lancet · 2020 · 761 citations · Full text

Medicine, Cardiology, Iron Metabolism Disorders +11

The effect of intravenous ferric carboxymaltose on health-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study

Ewa A. Jankowska, Bridget‐Anne Kirwan, Mikhail Kosiborod et al. · European Heart Journal · 2021 · 106 citations · Full text

Medicine, Cardiology, Internal Medicine +15

Rationale and Design of the AFFIRM-AHF Trial: A Randomised, Double-Blind, Placebo-Controlled Trial Comparing the Effect of Intravenous Ferric Carboxymaltose on Hospitalisations and Mortality in Iron-Deficient Patients Admitted for Acute Heart Failure

Piotr Ponikowski, Bridget‐Anne Kirwan, Stefan D. Anker et al. · European Journal of Heart Failure · 2019 · 53 citations · Full text

Medicine, Cardiology, Internal Medicine +13

Validation of the good outcome following attempted resuscitation score on in-hospital cardiac arrest in southern Sweden

Marcus Ohlsson, L. Kennedy, Mark H. Ebell et al. · International Journal of Cardiology · 2016 · 41 citations

Medicine, Cardiology, Emergency Medicine +8

Evaluation of pre-arrest morbidity score and prognosis after resuscitation score and other clinical variables associated with in-hospital cardiac arrest in southern Sweden

Marcus Ohlsson, L. Kennedy, Tord Juhlin et al. · Resuscitation · 2014 · 36 citations

Health Professions, Emergency Medical Services, Emergency Medicine +10